No Data
Procept BioRobotics Insider Sold Shares Worth $26,249,951, According to a Recent SEC Filing
BofA Securities Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Announces Target Price $104
PROCEPT BioRobotics Analyst Ratings
Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Announces Target Price $105
PROCEPT BioRobotics Will Not Receive Any Proceeds From Any Sale of Shares by Selling Stockholder >PRCT
PROCEPT BioRobotics: Selling Stockholder Granted Underwriters 30-day Option to Purchase up to an Additional 288,461 Shares at the Public Offering Price >PRCT
Yolo_tdm : thank u
Stock_Drift OP Yolo_tdm : YW. Appreciate it.
105711459 : Appreciate it, crazy performance by $Healthcare Triangle (HCTI.US)$
Boxman Stock_Drift OP : Nice volume here
Stock_Drift OP Boxman : Unusually nice.
View more comments...